These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7651889)

  • 1. Structure--function studies of vasopressin analogues with D-3 pyridyl-alanine in position 2.
    Sobocinska M; Derdowska I; Schwartz J; Kupryszewski G
    Peptides; 1995; 16(3):389-93. PubMed ID: 7651889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarities between hamster pancreatic islet beta (HIT) cell vasopressin receptors and V1b receptors.
    Richardson SB; Laya T; VanOoy M
    J Endocrinol; 1995 Oct; 147(1):59-65. PubMed ID: 7490538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A V1-type receptor for mediating the neurohypophysial hormone-induced ACTH release in trout pituitary.
    Pierson PM; Guibbolini ME; Lahlou B
    J Endocrinol; 1996 Apr; 149(1):109-15. PubMed ID: 8676042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
    Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
    J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.
    Derick S; Cheng LL; Voirol MJ; Stoev S; Giacomini M; Wo NC; Szeto HH; Ben Mimoun M; Andres M; Gaillard RC; Guillon G; Manning M
    Endocrinology; 2002 Dec; 143(12):4655-64. PubMed ID: 12446593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potent new synthetic analog of vasopressin with relative agonist specificity for the pituitary.
    Schwartz J; Derdowska I; Sobocinska M; Kupryszewski G
    Endocrinology; 1991 Aug; 129(2):1107-9. PubMed ID: 1649739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine vasopressin and its analogues--the influence of position 2 modification with 3,3-diphenylalanine enantiomers. Highly potent V2 agonists.
    Kwiatkowska A; Sobolewski D; Prahl A; Borovicková L; Slaninová J; Lammek B
    Eur J Med Chem; 2009 Jul; 44(7):2862-67. PubMed ID: 19418631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific receptors for vasopressin in the pituitary gland: evidence for down-regulation and desensitization to adrenocorticotropin-releasing factors.
    Koch B; Lutz-Bucher B
    Endocrinology; 1985 Feb; 116(2):671-6. PubMed ID: 2981673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed.
    Heinemann A; Horina G; Stauber RE; Pertl C; Holzer P; Peskar BA
    Br J Pharmacol; 1998 Nov; 125(6):1120-7. PubMed ID: 9863637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor.
    Antoni FA; Holmes MC; Makara GB; Kárteszi M; László FA
    Peptides; 1984; 5(3):519-22. PubMed ID: 6089144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of N-terminal part modification of arginine vasopressin analogues with 2-aminoindane-2-carboxylic acid: a highly potent V2 agonist.
    Kowalczyk W; Sobolewski D; Prahl A; Derdowska I; Borovicková L; Slaninová J; Lammek B
    J Med Chem; 2007 Jun; 50(12):2926-9. PubMed ID: 17500550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin, unlike phorbol ester, fails to synergistically interact with pituitary adenylate cyclase activating polypeptide (PACAP) in stimulating cyclic AMP formation and ACTH secretion in cultured anterior pituitary cells.
    Koch B; Lutz-Bucher B
    Mol Cell Endocrinol; 1993 Apr; 92(2):175-81. PubMed ID: 8391488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between CRF, epinephrine, vasopressin and glucocorticoids in the control of ACTH secretion.
    Labrie F; Giguere V; Proulx L; Lefevre G
    J Steroid Biochem; 1984 Jan; 20(1):153-60. PubMed ID: 6323861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin constricts outer medullary descending vasa recta isolated from rat kidneys.
    Turner MR; Pallone TL
    Am J Physiol; 1997 Jan; 272(1 Pt 2):F147-51. PubMed ID: 9039061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of 1-aminocyclohexane-1-carboxylic acid in position 2 or 3 of AVP and its analogues on their pharmacological properties.
    Jastrzebska B; Derdowska I; Kowalczyk W; Machova A; Slaninová J; Lammek B
    J Pept Res; 2003 Aug; 62(2):70-7. PubMed ID: 12823619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors.
    Manning M; Misicka A; Olma A; Klis WA; Bankowski K; Nawrocka E; Kruszynski M; Kolodziejczyk A; Cheng LL; Seto J
    J Med Chem; 1987 Dec; 30(12):2245-52. PubMed ID: 2960812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of renal vasopressin-stimulated adenylate cyclase by a vasopressor and antidiuretic antagonist, [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-ethyl)-D-tyrosine, 4-valine]arginine vasopressin.
    Chang P; Kimura K
    Biochem Biophys Res Commun; 1987 Apr; 144(2):770-8. PubMed ID: 3579941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4.
    Manning M; Olma A; Klis WA; Seto J; Sawyer WH
    J Med Chem; 1983 Nov; 26(11):1607-13. PubMed ID: 6631916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin.
    Manning M; Stoev S; Bankowski K; Misicka A; Lammek B; Wo NC; Sawyer WH
    J Med Chem; 1992 Jan; 35(2):382-8. PubMed ID: 1531076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.